Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £75.18m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Director/PDMR Dealing

Today 09:21

RNS Number : 5610J
Mpac Group PLC
24 June 2026
 

24 June 2026

 

Mpac Group plc

("Mpac" or the "Company")

 

Grant of Options

 

Director/PDMR Dealing

 

Mpac Group plc,  the global packaging and automation solutions Group, announces that on 22 June 2026, it awarded a total of 152,021 options to subscribe for new Ordinary Shares of 25 pence each in the Company ("Ordinary Shares") under the Mpac Group plc Long Term Incentive Plan ("LTIP") to certain of the Company's Directors/PDMRs in the amounts set out below:

Director/PDMR

Performance-related Options

Restricted Stock Units

Adam Holland, CEO

 

102,060

25,515

Duncan Tyler, Interim CFO

(non-board)

19,557

4,889

 

The Performance-related Options are exercisable at the nominal price of £0.25 and have vesting conditions tied to cumulative Earnings Per Share (EPS) and Return on Capital (ROCE). Each award will vest based on 50% of EPS performance and 50% of ROCE performance. Cumulative EPS must reach 85p over the performance period to vest in full. Vesting is nil if below 70p. The performance period in respect of Cumulative EPS is the period 1 January 2026 to 31 December 2028. The performance period for ROCE is the year ended 31 December 2028. ROCE for the year ended 31 December 2028 must reach 15% to vest in full. Vesting is nil if below 13%.

Restricted Stock Units are subject to the participant remaining an employee during the three-year vesting period ending 31 December 2028 and demonstrating performance and conduct satisfactory to the Remuneration Committee.

To the extent vested, the options will be subject to a two-year holding period following the vesting of the award. However, shares may be sold to cover any tax liability arising from exercise during the two-year holding period.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of a transaction by a person discharging managerial responsibilities ("PDMR").

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Holland

2

Reason for the notification

a)

Position/status

Chief Executive Officer / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan.

c)

Price(s) and volume(s)

102,060 performance-related options

25,515 restricted stock units

d)

Aggregated information

- Volume 

- Price

- Total

 

127,575

e)

Date of the transaction

22 June 2026

f)

Place of the transaction

N/A

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Duncan Tyler

2

Reason for the notification

a)

Position/status

Interim Chief Financial Officer / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan.

c)

Price(s) and volume(s)

19,557 performance-related options

4,889 restricted stock units

 

d)

Aggregated information

- Volume 

- Price

- Total

 

24,446

e)

Date of the transaction

22 June 2026

f)

Place of the transaction

N/A

 

 

For further information please contact:

 

Mpac Group plc

Adam Holland, Chief Executive Officer

Duncan Tyler, Interim Chief Financial Officer

 

 

Tel: +44 (0)24 7642 1100

 

 

Shore Capital (Nomad and Joint Broker)

Advisory

Patrick Castle

Sophie Collins

 

Broking

Henry Willcocks

 

Tel: +44 (0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Freddie Wooding

 

 

Tel: +44 (0)20 3100 2000

Tavistock

Nick Dibden

Katie Hopkins

Grace Cooper

 

Tel: +44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVZLBLQQLFBBV
Date   Source Headline
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar
27th Jul 20217:00 amRNSChange of Registered Office Address
26th Jul 202112:12 pmRNSMpac new contract
8th Jul 20217:00 amRNSTrading Update
5th May 20215:00 pmRNSResult of AGM
1st Apr 20214:30 pmRNSPosting of 2020 Annual Report and Notice of AGM
1st Apr 20214:27 pmRNSDirectors/PDMRs Dealing
30th Mar 20217:00 amRNSFull Year Results
11th Mar 20213:42 pmRNSEquity Development Investor Webinar Update
10th Mar 202112:02 pmRNSNotice of Results Update
1st Mar 20219:32 amRNSEquity Development Investor Webinar
17th Feb 20218:00 amRNSNotice of Results
7th Jan 20217:00 amRNSFull Year Trading Update
6th Oct 20203:56 pmRNSLaunch of new brand positioning and website
16th Sep 20209:51 amRNSDirector/PDMR Dealing
10th Sep 20203:37 pmRNSDirector/PDMR Dealing
9th Sep 20207:00 amRNSAcquisition of Switchback Group, Inc.
3rd Sep 20207:00 amRNSHalf year results
7th Aug 20208:00 amRNSEquity Development Investor Webinar
8th Jul 20204:41 pmRNSSecond Price Monitoring Extn
8th Jul 20204:36 pmRNSPrice Monitoring Extension
8th Jul 20202:08 pmRNSSecond Price Monitoring Extn
8th Jul 20202:01 pmRNSPrice Monitoring Extension
8th Jul 202011:06 amRNSSecond Price Monitoring Extn
8th Jul 202011:01 amRNSPrice Monitoring Extension
8th Jul 20209:06 amRNSSecond Price Monitoring Extn
8th Jul 20209:00 amRNSPrice Monitoring Extension
8th Jul 20207:00 amRNSOperating update and notice of results
6th May 20203:36 pmRNSResult of AGM
6th May 20207:00 amRNSAGM Statement
3rd Apr 20207:00 amRNSPosting of 2019 Annual Report and Notice of AGM
26th Mar 20207:00 amRNSCOVID-19, trading update and AGM
20th Mar 20202:08 pmRNSSecond Price Monitoring Extn
20th Mar 20202:01 pmRNSPrice Monitoring Extension
16th Mar 202011:06 amRNSSecond Price Monitoring Extn
16th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSBoard Change
4th Mar 20207:00 amRNSFull year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.